SCHEMBL21438596

SCHEMBL21438596

O=C(c1ccccc1CI)n1ccc2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
RAB9A P51151 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NOTUM Q6P988 1/20 0.50
KMT2A Q03164 1/20 0.41
MET P08581 1/20 0.39
LMNA P02545 1/20 0.38
CDK4 P11802 3/20 0.38
CCND1 P24385 3/20 0.38
TFPI2 P48307 1/20 0.37
NPY4R P50391 1/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28835530 0.80 TSHR (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL9654115 0.79 L3MBTL1 (0.69) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL28529485 0.76 RAB9A (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL21777692 0.76 TSHR (0.60) TSHRRAB9AL3MBTL1NOTUMLMNA
SCHEMBL29494636 0.76 RAB9A (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL28864285 0.76 TSHR (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL8447109 0.76 RAB9A (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL28921429 0.76 L3MBTL1 (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL9655173 0.73 L3MBTL1 (0.59) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL28244321 0.73 TSHR (0.55) TSHRRAB9AL3MBTL1NOTUMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3773563-A1 PRODRUGS OF FUSED-BICYCLIC C5AR ANTAGONISTS ChemoCentryx, Inc. (US) 2021-02-17 EP disclosed
WO-2019195159-A1 PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS CHEMOCENTRYX, INC. (US) 2019-10-10 WO disclosed